BETAMETHASONE DIPROPIONATE .5 mg/g
BETAMETHASONE DIPROPIONATE · OINTMENT, AUGMENTED · Aurobindo Pharma Limited
BETAMETHASONE DIPROPIONATE is a ointment, augmented containing betamethasone dipropionate at .5 mg/g, taken topical. Manufactured by Aurobindo Pharma Limited.
Key Facts
- Brand Name
- BETAMETHASONE DIPROPIONATE
- Generic Name
- BETAMETHASONE DIPROPIONATE
- NDC Code (Product)
59651-699- Manufacturer
- Aurobindo Pharma Limited
- Strength
- .5 mg/g
- Dosage Form
- OINTMENT, AUGMENTED
- Route
- TOPICAL
- Marketing Status
- Application #
- ANDA218289
- Marketing Start
- 04/10/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is BETAMETHASONE DIPROPIONATE used for?
BETAMETHASONE DIPROPIONATE contains BETAMETHASONE DIPROPIONATE. It is a ointment, augmented taken topical. Consult your doctor for specific uses.
Is BETAMETHASONE DIPROPIONATE a controlled substance?
BETAMETHASONE DIPROPIONATE is not classified as a controlled substance by the DEA.
What is the generic name for BETAMETHASONE DIPROPIONATE?
The generic name for BETAMETHASONE DIPROPIONATE is BETAMETHASONE DIPROPIONATE. There are 11 other brand versions of BETAMETHASONE DIPROPIONATE.
What is the NDC code for BETAMETHASONE DIPROPIONATE .5 mg/g?
The NDC (National Drug Code) for BETAMETHASONE DIPROPIONATE .5 mg/g is 59651-699, listed by Aurobindo Pharma Limited.
Other Betamethasone Brands
See all →- Betamethasone Dipropionate.5 mg/g0472-0381
- Betamethasone Dipropionate.5 mg/mL21922-104
- Betamethasone Dipropionate.5 mg/mL0168-0057
- Betamethasone Dipropionate.5 mg/g50090-0235
- Betamethasone dipropionate.5 mg/g51672-1390
- betamethasone dipropionate.5 mg/g72578-093
- DIPROLENE.5 mg/g78206-124
- Betamethasone Dipropionate.5 mg/g0168-0056
- Betamethasone Dipropionate.5 mg/g45802-376
- Betamethasone Dipropionate.5 mg/g50090-3276
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)